# Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

> **NCT01301157** · PHASE2 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 294 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** M518101
- **DRUG:** placebo
- **DRUG:** Dovonex

## Key facts

- **NCT ID:** NCT01301157
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2015-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301157, "Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01301157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*